PD
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Admission to intensive care: A qualitative study of triage and its determinants | Health Services Research | 2018 | 559 | 3 | |||
| Volunteers trained in palliative care at the hospital: An original and dynamic resource | Palliative & supportive care | 2015 | 866 | 0 | |||
| Providing Quality Therapeutics in Switzerland: Role of the Stakeholders and Recent Incentives for Further Improvements | Clinical therapeutics | 2015 | 721 | 6 | |||
| P-glycoprotein: a clue to vitamin K antagonist stabilization | Pharmacogenomics | 2015 | 705 | 0 | |||
| Cannabinoïdes médicaux dans les douleurs chroniques : aspects pharmacologiques | Revue médicale suisse | 2015 | 695 | 5 | |||
| Drug-related problems identification in general internal medicine: The impact and role of the clinical pharmacist and pharmacologist | European journal of internal medicine | 2015 | 740 | 6 | |||
| Monitoring white blood cell count in adult patients with schizophrenia who are taking clozapine: a cost-effectiveness analysis | The Lancet. Psychiatry | 2014 | 560 | 0 | |||
| Incorporation of Flurbiprofen in a 4-Drug Cytochrome P450 Phenotyping Cocktail | Basic & clinical pharmacology & toxicology | 2014 | 652 | 4 | |||
| Doctors' Decisions When Faced With Contradictory Patient Advance Directives and Health Care Proxy Opinion: A Randomized Vignette-Based Study | Journal of pain and symptom management | 2014 | 663 | 0 | |||
| Geneva Cocktail for Cytochrome P450 and P-glycoprotein Activity Assessment Using Dried Blood Spots | Clinical pharmacology and therapeutics | 2014 | 928 | 572 | |||
| Impact of Advance Directives and a Health Care Proxy on Doctors' Decisions: A Randomized Trial | Journal of pain and symptom management | 2014 | 658 | 0 | |||
| Central Pain Sensitization, COMT Val158Met Polymorphism, and Emotional Factors in Fibromyalgia | The journal of pain | 2014 | 740 | 2 | |||
| Identification and weighting of the most critical "real-life" drug-drug interactions with acenocoumarol in a tertiary care hospital | European journal of clinical pharmacology | 2013 | 879 | 979 | |||
| Antihyperalgesic Effect of the GABA(A) Ligand Clobazam in a Neuropathic Pain Model in Mice: A Pharmacokinetic-Pharmacodynamic Study | Basic & clinical pharmacology & toxicology | 2013 | 651 | 462 | |||
| Patented drug extension strategies on healthcare spending: a cost-evaluation analysis | PLoS medicine | 2013 | 750 | 410 | |||
| Role of P-glycoprotein in the uptake/efflux transport of oral vitamin K antagonists and rivaroxaban through the Caco-2 cell model | Basic & clinical pharmacology & toxicology | 2013 | 604 | 3 | |||
| Intraocular penetration of penciclovir after oral administration of famciclovir: a population pharmacokinetic model | The journal of antimicrobial chemotherapy | 2013 | 591 | 0 | |||
| Pharmacokinetic interaction between prasugrel and ritonavir in healthy volunteers | Basic & clinical pharmacology & toxicology | 2013 | 666 | 450 | |||
| Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: a randomized, double-blind, placebo-controlled trial | Pain physician | 2013 | 630 | 1,155 | |||
| Influence of CYP2D6 activity on pre-emptive analgesia by the N-methyl-D-aspartate antagonist dextromethorphan in a randomized controlled trial of acute pain | Pain physician | 2013 | 801 | 774 | |||
| Drug-induced long QT in adult psychiatric inpatients: the 5-year cross-sectional ECG Screening Outcome in Psychiatry study | The American journal of psychiatry | 2013 | 687 | 1 | |||
| Impact of CYP2C9 polymorphisms on the vulnerability to pharmacokinetic drug-drug interactions during acenocoumarol treatment | Pharmacogenomics | 2013 | 694 | 0 | |||
| Evidence of Drug-Drug Interactions through Uptake and Efflux Transport Systems in Rat Hepatocytes: Implications for Cellular Concentrations of Competing Drugs | Drug metabolism and disposition | 2013 | 817 | 722 | |||
| Transcriptional regulation of CYP2C19 and its role in altered enzyme activity | Current drug metabolism | 2012 | 612 | 0 | |||
| Psychological distress in fibromyalgia patients: a role for catechol-O-methyl-transferase Val158met polymorphism | Health psychology review | 2012 | 830 | 740 | |||
| Quel programme informatique de détection des interactions médicamenteuses néfastes ? | Revue médicale suisse | 2012 | 983 | 1,026 | |||
| Validation of the simplified UVB model to assess the pharmacodynamics of analgesics in healthy human volunteers | Chimia | 2012 | 809 | 1,183 | |||
| Pharmacokinetic-pharmacodynamic modelling of opioids in healthy human volunteers. A minireview | Basic & clinical pharmacology & toxicology | 2012 | 659 | 797 | |||
| Fracture atypique du fémur sous bisphosphonates, un effet indésirable à ne pas manquer | Revue médicale suisse | 2012 | 621 | 0 | |||
| The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitro | British journal of pharmacology | 2012 | 593 | 0 | |||
| Oral flurbiprofen metabolic ratio assessment using a single-point dried blood spot | Clinical pharmacology and therapeutics | 2012 | 656 | 0 | |||
| A simplified method for busulfan monitoring using dried blood spot in combination with liquid chromatography/tandem mass spectrometry | RCM. Rapid communications in mass spectrometry | 2012 | 849 | 949 | |||
| A randomized, controlled trial validates a peripheral supra-additive antihyperalgesic effect of a paracetamol-ketorolac combination | Basic & clinical pharmacology & toxicology | 2011 | 682 | 0 | |||
| Ritonavir inhibits the two main prasugrel bioactivation pathways in vitro: a potential drug-drug interaction in HIV patients | Metabolism, clinical and experimental | 2011 | 693 | 0 | |||
| ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia | Pharmacogenomics | 2011 | 960 | 6 | |||
| Automated system for on-line desorption of dried blood spots applied to LC/MS/MS pharmacokinetic study of flurbiprofen and its metabolite | Journal of pharmaceutical and biomedical analysis | 2011 | 746 | 958 | |||
| Uptake/efflux transport of tramadol enantiomers and O-desmethyl-tramadol: focus on P-glycoprotein | Basic & clinical pharmacology & toxicology | 2009 | 645 | 2 | |||
| Two-dimensional liquid chromatography-ion trap mass spectrometry for the simultaneous determination of ketorolac enantiomers and paracetamol in human plasma: application to a pharmacokinetic study | Journal of chromatography | 2009 | 566 | 0 | |||
| The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction | Pharmacogenomics journal | 2009 | 918 | 0 | |||
| Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital | Drug safety | 2009 | 626 | 0 | |||
| P-glycoprotein is not involved in the differential oral potency of naloxone and naltrexone | Fundamental & clinical pharmacology | 2009 | 681 | 0 | |||
| Pharmacogenetics of analgesics: toward the individualization of prescription | Pharmacogenomics | 2008 | 574 | 0 | |||
| Influence of ABCB1 gene polymorphisms and P-glycoprotein activity on cyclosporine pharmacokinetics in peripheral blood mononuclear cells in healthy volunteers | Drug metabolism letters | 2008 | 864 | 0 | |||
| New approaches to the pharmacotherapy of neuropathic pain | Expert review of clinical pharmacology | 2008 | 590 | 0 | |||
| La prescription « off-label » | Revue médicale suisse | 2008 | 700 | 0 | |||
| Lack of interaction of the NMDA receptor antagonists dextromethorphan and dextrorphan with P-glycoprotein | Current drug metabolism | 2008 | 659 | 4 | |||
| Development and validation of a chemical hydrolysis method for dextromethorphan and dextrophan determination in urine samples: application to the assessment of CYP2D6 activity in fibromyalgia patients | Journal of chromatography. B | 2008 | 629 | 4 | |||
| Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study | Clinical therapeutics | 2007 | 774 | 0 | |||
| Anticoagulation orale et pharmacogénétique : perspectives pour la pratique clinique | Revue médicale suisse | 2007 | 412 | 0 | |||
| Patients' representations of antidepressants: a clue to nonadherence? | The Clinical journal of pain | 2007 | 520 | 1 | |||
| CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis | European journal of clinical pharmacology | 2006 | 665 | 617 | |||
| Entre sel et gènes ou pharmacogénomique des antihypertenseurs | Revue médicale suisse | 2006 | 419 | 0 | |||
| Prise en charge médicamenteuse des troubles psychologiques et comportementaux lies à la démence | Revue médicale suisse | 2006 | 488 | 0 | |||
| Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors | Archives of internal medicine | 2006 | 493 | 478 | |||
| Polymorphisme génétique et interactions médicamenteuses: leur importance dans le traitement de la douleur | Canadian journal of anaesthesia | 2005 | 555 | 536 | |||
| Systemic allergic reaction and diffuse bone pain after exposure to a preparation of betamethasone | European journal of internal medicine | 2005 | 445 | 0 | |||
| Development and validation of a new reversed-phase ion pairing liquid chromatographic method with fluorescence detection for penciclovir analysis in plasma and aqueous humor | Journal of chromatography. B | 2005 | 615 | 2 | |||
| Sélection d'un médicament dans une classe thérapeutique donnée : l'exemple des «inhibiteurs de l'HMG-CoA réductase» | Revue médicale suisse | 2005 | 390 | 0 | |||
| Le traitement de l'hypertension artérielle : un défi pour le praticien | Revue médicale suisse | 2005 | 477 | 0 | |||
| QT interval prolongation in patients on methadone with concomitant drugs | Journal of clinical psychopharmacology | 2004 | 485 | 0 | |||
| Codeine intoxication associated with ultrarapid CYP2D6 metabolism | The New England journal of medicine | 2004 | 563 | 1 | |||
| Neurophysiologic evidence for a central sensitization in patients with fibromyalgia | Arthritis and rheumatism | 2003 | 551 | 925 | |||
| Clinical pharmacology and rationale of analgesic combinations | European journal of anaesthesiology. Supplement | 2003 | 402 | 0 | |||
| Advances with analgesics and NSAIDs for the treatment of spinal disorders | Baillière's best practice & research. Clinical rheumatology | 2002 | 496 | 717 | |||
| Simultaneous stereoselective analysis of tramadol and its main phase I metabolites by on-line capillary zone electrophoresis-electrospray ionization mass spectrometry | Journal of chromatography | 2000 | 709 | 0 | |||
| Contribution of cytochrome P-4502D6 phenotype to the neuromodulatory effects of dextromethorphan | The Journal of pharmacology and experimental therapeutics | 1999 | 377 | 298 | |||
| Use of the label "litigation neurosis" in patients with somatoform pain disorder | General hospital psychiatry | 1998 | 482 | 237 | |||
| Lack of acetaminophen ceiling effect on R-III nociceptive flexion reflex | European journal of clinical pharmacology | 1998 | 540 | 0 | |||
| Pharmacologie du tramadol | Drugs | 1997 | 759 | 2 | |||
| Stereoselective interaction between piroxicam and acenocoumarol | British journal of clinical pharmacology | 1996 | 649 | 7 | |||
| Influence of rifampin on fleroxacin pharmacokinetics | Antimicrobial agents and chemotherapy | 1993 | 665 | 0 | |||
| In vitro forecasting of drugs that may interfere with codeine bioactivation | European journal of drug metabolism and pharmacokinetics | 1992 | 430 | 177 | |||
| Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI) | Biochemical and biophysical research communications | 1988 | 427 | 577 |
